BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7058043)

  • 1. Investigation of circulating immune complexes in patients with breast cancer.
    Horváth M; Fekete B; Rahóty P
    Oncology; 1982; 39(1):20-2. PubMed ID: 7058043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes in patients with breast cancer.
    Hoffken K; Meredith ID; Robins RA; Baldwin RW; Davies CJ; Blamey RW
    Br Med J; 1977 Jul; 2(6081):218-20. PubMed ID: 884444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer.
    Neri B; Comparini T; Ciatto S; Cataliotti L; Distante V; Bartalucci S
    Cancer Detect Prev; 1985; 8(1-2):53-6. PubMed ID: 4064052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Circulating and tumor tissue-bound immune complexes in patients with breast cancer].
    Dorosevich AE
    Arkh Patol; 1983; 45(7):30-6. PubMed ID: 6354144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating immune complexes and complement factors in patients following cardiosurgical operations].
    Maerker-Alzer G; Dienst C; Schumacher K; Kiemen HB; Rahman A; Hügel W; Dalichau H
    Immun Infekt; 1985 Apr; 13(2):83-5. PubMed ID: 3997194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune complex-like materials in sera of patients with breast cancer: detection by complement-consumption assay.
    Sulitzeanu D; Asaf O; Biran S; Brufman G; Gilead Z
    Isr J Med Sci; 1981; 17(9-10):869-73. PubMed ID: 7309475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating immune complexes and immunologic reactivity in breast cancer].
    Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG
    Eksp Onkol; 1984; 6(3):50-2. PubMed ID: 6333978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes in patients with IgA glomerulonephritis.
    Nagy J; Füst G; Ambrus M; Trinn C; Paál M; Burger T
    Acta Med Acad Sci Hung; 1982; 39(3-4):211-8. PubMed ID: 6985242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating immune complexes in breast cancer].
    Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
    Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis.
    Kerr MA; Wilton E; Naama JK; Whaley K
    Clin Exp Immunol; 1986 Feb; 63(2):359-66. PubMed ID: 3698338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulating immune complexes and the complement level in children with acute pneumonia].
    Popova OIa; Rodshteĭn OA; Kositskaia LS; Shteĭnlukht PL
    Ter Arkh; 1985; 57(5):42-5. PubMed ID: 2410992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circulating immune complexes and the prognosis of cancer].
    Carpentier N
    Rev Med Suisse Romande; 1983 Jul; 103(7):601-2. PubMed ID: 6635408
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients.
    Iaffaioli RV; Bianchin A; Ruggiero G; Pirozzi G; Ungaro A; Totaro G; Gallo C; De Placido S; Pagliarulo C; Bianco AR
    Oncology; 1988; 45(5):337-43. PubMed ID: 3412739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes and serum complement in Nigerian patients with non-A, non B hepatitis.
    Ayoola EA
    East Afr Med J; 1984 Oct; 61(10):752-6. PubMed ID: 6442978
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immune complexes in neoplastic diseases and autoimmune processes].
    Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG; Vygovskaia IaI; Zakharchuk LS
    Vopr Onkol; 1983; 29(8):3-7. PubMed ID: 6613066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes of IgG1 and IgG3 subclasses in human breast cancer sera detected by monoclonal antibodies in an indirect immunoenzymatic assay.
    Manzo C; Bianchin A; Pirozzi G; Totaro G
    Oncology; 1983; 40(6):395-9. PubMed ID: 6358985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of killer cell activity & circulating immune complex levels in patients with breast cancer.
    Kundu S; Sharma LK; Seth P
    Indian J Med Res; 1988 Oct; 88():330-5. PubMed ID: 3225017
    [No Abstract]   [Full Text] [Related]  

  • 18. Serial circulating immune complex values and development of metastatic disease in breast cancer and malignant melanoma patients.
    Ronai Z; Shaham J; Stein J; Sulitzeanu D
    Cancer Immunol Immunother; 1986; 22(1):72-5. PubMed ID: 3518930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behaviour of immune complexes and the complement system in normal pregnancy and pre-eclampsia.
    Schena FP; Manno C; Selvaggi L; Loverro G; Bettocchi S; Bonomo L
    J Clin Lab Immunol; 1982 Jan; 7(1):21-6. PubMed ID: 7069775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating immune complexes in carcinoma of uterine cervix.
    Seth P; Balachandran N; Malaviya AN; Kumar R
    Clin Exp Immunol; 1979 Oct; 38(1):77-82. PubMed ID: 527257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.